نتایج جستجو برای: mrd

تعداد نتایج: 1567  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013
Cornelia Eckert Günter Henze Karlheinz Seeger Nikola Hagedorn Georg Mann Renate Panzer-Grümayer Christina Peters Thomas Klingebiel Arndt Borkhardt Martin Schrappe André Schrauder Gabriele Escherich Lucie Sramkova Felix Niggli Johann Hitzler Arend von Stackelberg

PURPOSE In children with intermediate risk of relapse of acute lymphoblastic leukemia (ALL), it is essential to identify patients in need of treatment intensification. We hypothesized that the prognosis of patients with unsatisfactory reduction of minimal residual disease (MRD) can be improved by allogeneic hematopoietic stem-cell transplantation (HSCT). PATIENTS AND METHODS In the Acute Lymp...

2010
Kyung Nam Koh Meerim Park Bo Eun Kim Ho Joon Im Chan-Jeoung Park Seongsoo Jang Hyun Sook Chi Jong Jin Seo

PURPOSE Our study attempted to determine the prognostic significance of minimal residual disease (MRD) detected by a simplified flow cytometric assay during induction chemotherapy in children with B-cell acute lymphoblastic leukemia (B-ALL). METHODS A total of 98 patients were newly diagnosed with precursor B-ALL from June 2004 to December 2008 at the Asan Medical Center (Seoul, Korea). Of th...

Journal: :Blood 1992
K Miyamura M Tanimoto Y Morishima K Horibe K Yamamoto M Akatsuka Y Kodera S Kojima K Matsuyama N Hirabayashi

Minimal residual disease (MRD) in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1 ALL) who received allogeneic (n = 9) or autologous (n = 6) bone marrow transplantation (BMT) was evaluated by the polymerase chain reaction (PCR) for the bcr-abl transcript. Twelve patients received BMT at the time of hematologic and cytogenetic remission. However, MRD was detected...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012
Hiroto Inaba Elaine Coustan-Smith Xueyuan Cao Stanley B Pounds Sheila A Shurtleff Kathleen Y Wang Susana C Raimondi Mihaela Onciu Jeffrey Jacobsen Raul C Ribeiro Gary V Dahl W Paul Bowman Jeffrey W Taub Barbara Degar Wing Leung James R Downing Ching-Hon Pui Jeffrey E Rubnitz Dario Campana

PURPOSE In acute myeloid leukemia (AML), initial treatment response by morphologic analysis of bone marrow predicts long-term outcome. Response can now be assessed by minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain reaction (PCR). We determined the relation among the results of these approaches and their prognostic value. PATIENTS AND METHODS In the multicent...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Aaron C Logan Hong Gao Chunlin Wang Bita Sahaf Carol D Jones Eleanor L Marshall Ismael Buño Randall Armstrong Andrew Z Fire Kenneth I Weinberg Michael Mindrinos James L Zehnder Scott D Boyd Wenzhong Xiao Ronald W Davis David B Miklos

The primary cause of poor outcome following allogeneic hematopoietic cell transplantation (HCT) for chronic lymphocytic leukemia (CLL) is disease recurrence. Detection of increasing minimal residual disease (MRD) following HCT may permit early intervention to prevent clinical relapse; however, MRD quantification remains an uncommon diagnostic test because of logistical and financial barriers to...

2015
Mariateresa Fulciniti Nikhil C. Munshi Joaquin Martinez-Lopez

Novel and more effective treatment strategies against multiple myeloma (MM) have significantly prolonged patients' survival and raised interest in the depth of response and its association with clinical outcome. Minimal residual disease (MRD) has emerged as one of the most relevant prognostic factors in MM and should be included in a new definition of complete response (CR). Although further st...

Journal: :Genome research 1995
M Faham D R Cox

Mismatch repair detection (MRD) is an in vivo method that uses a change in bacterial colony color to detect DNA sequence variation. DNA fragments to be screened for variation are cloned into two MRD plasmids, and bacteria are transformed with heteroduplexes of these constructs. The resulting colonies are blue in the absence of a mismatch and white in the presence of a mismatch. MRD is capable o...

Journal: :Leukemia & Lymphoma 2021

The Swedish national guidelines for treatment of acute myeloid leukemia (AML) recommend analysis measurable residual disease (MRD) by multiparameter flow cytometry (MFC) in bone marrow the routine clinical setting. AML registry contains such MRD data patients diagnosed 2011-2019. Of 327 with (non-APL) MRD-results reported complete remission after two courses intensive chemotherapy 229 were MRD-...

2003
Nancy C. Jordan Laurie B. Hanich

The reading and mathematics achievement and specific mathematical competencies of 74 children were followed over four time points during second and third grades. At the beginning of the study, children were classified into one of four groups: moderate mathematics deficiencies but normal reading (MMD-only); moderate mathematics and reading deficiencies (MMD/MRD); moderate reading deficiencies bu...

2014
R Silvennoinen T Lundan V Kairisto T-T Pelliniemi M Putkonen P Anttila V Huotari P Mäntymaa S Siitonen L Uotila T-L Penttilä V Juvonen T Selander K Remes

Multiparameter flow cytometry (MFC) and allele-specific oligonucleotide real-time quantitative PCR (ASO RQ-PCR) are the two most sensitive methods to detect minimal residual disease (MRD) in multiple myeloma (MM). We compared these methods in 129 paired post-therapy samples from 22 unselected, consecutive MM patients in complete/near complete remission. Appropriate immunophenotypic and ASO RQ-P...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید